FineMark National Bank & Trust’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-115,062
Closed -$169K 1496
2016
Q2
$169K Buy
115,062
+10,000
+10% +$8.68K 0.02% 330
2016
Q1
$134K Buy
105,062
+32,255
+44% +$37.3K 0.02% 364
2015
Q4
$140K Buy
72,807
+50,000
+219% +$94.9K 0.02% 379
2015
Q3
$41K Hold
22,807
0.01% 679
2015
Q2
$48K Hold
22,807
0.01% 672
2015
Q1
$156K Hold
22,807
0.02% 390
2014
Q4
$156K Hold
22,807
0.02% 397
2014
Q3
$157K Hold
22,807
0.03% 379
2014
Q2
$153K Hold
22,807
0.03% 373
2014
Q1
$182K Hold
22,807
0.03% 334
2013
Q4
$130K Sell
22,807
-5,000
-18% -$25.6K 0.03% 382
2013
Q3
$114K Hold
27,807
0.03% 398
2013
Q2
$90K Buy
+27,807
New +$78.9K 0.03% 417

Other funds holding TTHI

FineMark National Bank & Trust's TTHI Position: Q3 2016 in Review

FineMark National Bank & Trust sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 115,062 shares — an estimated $169K sold.

FineMark National Bank & Trust first reported a position in TTHI in Q2 2013 and held it in 13 quarters. The position peaked at $182K in Q1 2014. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • FineMark National Bank & Trust reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • FineMark National Bank & Trust sold 115,062 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $169K.
  • FineMark National Bank & Trust first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 13 quarters.
  • FineMark National Bank & Trust's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $182K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on FineMark National Bank & Trust's 13F filing for Q3 2016, filed 10 Nov 2016.